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ABSTRACT. Osteoporosis is the net result of the
maximal amount of bone mineral mass achieved by
the end of pubertal growth (peak bone mass) minus
post-menopausal and elderly bone losses. Peak
bone mineral mass is determined from early child-
hood by both heritable and environmental factors.
Recent developments in the molecular epidemiol-
ogy of osteoporosis have shown the interest, but al-
so the limitations, of specific molecular markers,
such as the vitamin D receptor gene polymor-
phisms Bsm 1 and Fok 1, to explain bone mineral
density differences across the population. Impor-
tantly, however, interactions between VDR gene
polymorphisms and environmental factors, par-
ticularly dietary calcium, have provided new in-
sights into the complex determination of bone
mineral mass.
(Aging Clin. Exp. Res. 10: 205-213, 1998)
©1998, Editrice Kurtis
INTRODUCTION
Osteoporosis is a common disorder which de-
pends on both the amount of bone mineral mass ac-
quired during growth, and postmenopausal as well as
age-related bone losses. Although a vast majority of
studies aiming at preventing the occurrence of os-
teoporotic fractures focused on slowing bone miner-
al density (BMD) losses by a variety of dietary and
pharmacologic interventions, the risk of osteoporosis
up to the seventh decade is mostly determined by peak
bone mineral mass. Therefore, the determinants of
BMD growth during childhood have recently emerged
as essential factors to understand the prevalence of os-
teoporosis. 
We review here the influence of heritable and di-
etary factors on bone mineral mass acquisition in
childhood and maintenance in aging adults, with par-
ticular attention to the interaction between calcium in-
take and recently identified allelic polymorphisms in
the vitamin D receptor gene.
BONE MINERAL MASS HEREDITY
Non-invasive techniques capable of measuring
BMD with great precision and accuracy, such as dual
X-ray absorptiometry (DXA) (1), have led to a clear
definition of osteoporosis, which is a BMD below
minus 2.5 standard deviations from the mean BMD in
young adults of the same sex, and consequently to es-
timate the relative risk of skeletal fractures in relation
to BMD (2), although many other factors certainly play
a role in the occurrence of osteoporotic fractures. An
evaluation of health status, dietary and life-style habits,
as well as a family history of osteoporosis, may orient
towards an increased risk of osteoporotic fractures (3).
Concerning the importance of a positive family
history of osteoporosis, indeed it was shown that
daughters of osteoporotic females had a decreased
BMD (4). Moreover, several studies have established
clear evidence for a familial resemblance of bone
mineral mass, and demonstrated that a fair amount of
the BMD variance across the population could be
explained by genetic factors, which are known as
heritability (5). For this purpose, two kinds of hu-
man models have been used. In the twin model, with-
in-pairs correlations for BMD are compared between
monozygotic (MZ) twins, who by essence share 100%
of their genes, and dizygotic twins, who have 50% of
their genes in common. Stronger correlation coeffi-
cients among adult MZ as compared to DZ twins are
indicative of a strong genetic influence on peak bone
mineral mass, accounting for as much as 80% of
lumbar spine and proximal femur BMD (6). Parents-
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offspring comparisons have also shown significant
relationships for BMD, albeit heritability estimates
have been somewhat lower (in the range of 60%) than
in the twin model (7). Actually, the magnitude of direct
genetic effects on peak bone mineral mass as evalu-
ated in such human models may be overestimated by
similarities in environmental covariates (8, 9), as well
as by indirect genetic effects on bone mass through
the determination of lean body mass (10).
In an attempt to redefine the actual heritability for
bone mineral mass, as well as establish the age at
which genetic factors operating on various bone min-
eral mass constituents are expressed, we recently in-
vestigated correlations for bone mineral content
(BMC, g), areal and volumetric bone mineral density
(BMD, g/cm2 and BMAD, g/cm3, respectively) and
bone area (BA, cm2) at the lumbar spine (LS) and fe-
mur (neck, FN, trochanter, FT, and diaphysis, FS) in
138 premenopausal women (mean age ± SD,
40.0±4.0 years) and their prepubertal daughters
(8.1±0.7 years) (11). Regressions were further adjusted
for height, weight and calcium intake, such as to
minimize the impact of indirect genetic effects, as
well as of dietary influences on bone mineral mass re-
semblance among relatives. The results indicated that
despite great disparities in the maturity of the various
constituents of bone mineral mass before puberty
with respect to peak adult values, ranging from 33%
for LS BMC to 100% for FN BMAD, heredity by ma-
ternal descent was detectable at all skeletal sites, and
affected virtually all bone mineral mass constituents
(Fig. 1). Moreover, when daughters bone values were
reevaluated two years later, when puberty had begun
and bone mineral mass had considerably increased,
measurements were highly correlated with prepu-
bertal values (all r >0.80), whereas mother-daughter
correlations had remained unchanged.
By the age of 16 to 18 years in females, and 18 to
20 years in males, bone mineral mass growth virtually
ceases, but a marked scattering of BMD values for
both genders is then apparent across the population
(12, 13). A major proportion of this variance is due to
genetic factors which are already expressed before pu-
berty, with subsequent tracking of bone mineral mass
constituents through the phase of rapid pubertal
growth until peak bone mass is achieved.
In contrast, it is presently unclear whether genetic
effects also operate on bone turnover and the rate of
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Figure 1 - Correlations of bone mineral mass constituents between prepubertal daughters and their premenopausal mothers. Areal
bone mineral density (BMD, g/cm2), bone mineral content (BMC, g), bone area (Area, cm2) and volumetric bone mineral density (BMAD,
g/cm3) were standardized for age (Z-scores). Pearson’s correlation coefficients (r) for the various measures were 0.31-0.36 at both lum-
bar spine and femoral neck, except lumbar spine BMAD (r=0.24). All were significant at p<0.01. Adapted from Ferrari S. et al.(11),
with permission.
3
2
1
0
-1
-2
-3
-4
-3 -2 -1 0 1 2 3 4
Femoral neck
BMD BMC Area BMAD
Lumbar spine
BMD BMC Area BMAD
4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3 4
4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3 4
4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3 4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3
4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3 4
4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3
4
3
2
1
0
-1
-2
-3
-3 -2 -1 0 1 2 3
post-menopausal and age-related bone losses (5). In
this regard, an important, although often overlooked,
analysis of familial resemblance for bone mineral
mass expanding over three generations showed an ab-
sence of correlations between grand-mothers and
their grand-daughters BMD (14), suggesting that non-
genetic, generation-related factors (such as secular
trends for changes in nutrient intake) and/or post-
menopausal estrogen deprivation could overcome
genetic effects on peak bone mineral mass in the
later determination of osteoporosis (14).
NUTRITION AND BONE MINERAL MASS
As opposed to the predominant genetic effects
on bone mineral mass acquisition, rather than main-
tenance and rate of loss, nutritional factors have long
been considered to exert a major influence on the risk
and prevention of osteoporosis during late life years.
A body of epidemiological and prospective studies
have indeed indicated the importance of protein intake
(15-17) and mostly calcium and vitamin D (18-23) for
maintaining BMD and decreasing the incidence of os-
teoporotic fractures in the elderly.
Increasing calcium intake during childhood and
adolescence has more recently also been advocated in
order to improve bone mineral accrual during growth,
and thereby potentially increase peak bone mineral
mass (24). Analyses of the relationships between
BMD and spontaneous calcium intake in the young,
however, show a poor and sometimes absent corre-
lation between these two variables (25). A few
prospective randomized intervention trials examined
the effects of calcium supplements in children and ado-
lescents, and found variable influences according to the
subject’s age, the skeletal sites examined and the
baseline calcium intake (26-28). Nevertheless, we re-
cently demonstrated a remarkable increase in BMD
gain in the appendicular skeleton in 144 prepubertal
girls receiving calcium-supplements (850 mg/day)
for one year, compared with placebo, particularly
when their spontaneous calcium intake was less than
880 mg/day (the median of the cohort), a value sim-
ilar to the RDA at that age (Fig. 2). Interestingly, in
that study we observed that calcium supplements not
only positively influenced BMD gain, but also bone
area and height. This suggests that calcium was ef-
fective on the various constituents of bone mineral
mass. Although it has not yet been proven that early
dietary intervention, such as increasing calcium intake
in childhood, will result in a determinant increase in
peak bone mineral mass, our observation of increased
bone dimensions, and persistant BMD differences
between calcium and placebo-treated subjects one
year after cessation of the trial suggests that a higher
bone mineral mass achieved during childhood might
be maintained later on (28).
In summary, peak bone mineral mass is deter-
mined by both genetic and environmental factors
which, either independently or through some mutual
interactions, model the various constituents of ap-
parent BMD from early childhood. On the other
hand, hormonal and environmental factors seem to
play a predominant role in bone remodeling and
bone loss. The role of genetics in the latter phe-
nomenon, however, still has to be elucidated (see
below) (Fig. 3). 
VITAMIN D RECEPTOR GENE
POLYMORPHISMS AND BONE MINERAL
MASS
DNA single base variations scattered through the
human genome are known as allelic polymorphisms
if they occur in at least 1% of the general population.
Such polymorphisms constitute markers of the genetic
diversity between individuals, and are potentially in-
teresting tools in order to identify a heritable predis-
position to common disorders, such as arteriosclero-
sis or diabetes (29). More recently, the characterization
Genetics of osteoporosis
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Figure 2 - Effects of calcium supplements on BMD gain in pre-
pubertal girls. The percentage increase in BMD gain at various
skeletal sites over one year due to calcium supplements (850
mg/day) was calculated as the mean BMD gain in the calcium
group minus the mean BMD gain in the placebo group divided
by the mean BMD gain in the placebo group. “All” is the aver-
age of the six skeletal sites as shown. Dotted and open bars in-
dicate subjects with spontaneous calcium intake respectively be-
low and over the median of the entire cohort (880 mg/day).
*p<0.05; #p<0.01 Adapted from Bonjour J-P. et al. (28), with
permission.
of polymorphic loci in genes coding for molecules im-
plicated in bone structure and metabolism has given
rise to an impressive number of molecular epidemi-
ology investigations in the field of osteoporosis as
well. Among the various candidate genes which have
been more or less successfully associated with BMD
(Table 1), the Vitamin D receptor alleles are by far the
most extensively analyzed and the better defined.
VDR-3’ allelic polymorphisms
Among a number of common allelic polymor-
phisms in the 3’-end region of the VDR gene, the
one recognized by the endonuclease restriction en-
zyme Bsm 1 appears to be the most informative (30,
31), (another polymorphic site, Taq 1, in close
vicinity to Bsm 1, and therefore in perfect linkage
disequilibrium with Bsm 1, has also been alternatively
used in some association studies, in which case, tt, Tt
and TT genotypes are equivalent to BB, Bb and
bb, respectively). Thus, genotypes BB (prevalence in
the Caucasian population, 15%), Bb (50%) and bb
(35%), were first associated with significant differ-
ences in mean osteocalcin levels in a mixed cohort of
both healthy males and females, particularly the
subgroup of postmenopausal women (30). Morrison
et al. later observed a marked reduction in BMD vari-
ance among DZ twins sharing identical VDR 
3’-end alleles (31), which was suggestive of their
major contribution to the genetic determination of
BMD. Unfortunately, these results seemed to be
weakened by some technical and analytical errors.
The most important observations, however, were the
lower BMD at the lumbar spine and proximal femur
associated with the B allele in adult twins of both
genders, as well as in unrelated pre- and post-
menopausal women, both of European descent,
and the higher rate of bone loss after menopause
(31). 
A large number of subsequent studies reported
highly controversial results concerning the relationship
between BMD or bone turnover and VDR-3’ allelic
polymorphisms (32, 33). Indeed, other workers failed
to detect significant osteocalcin differences among
VDR-3’ alleles, or in the level of several markers of
bone resorption (34, 35). Linkage studies in twins did
not confirm a significant association of VDR-3’ gene
polymorphisms and BMD heritability (36). Regarding
association studies between BMD and VDR-3’ alleles,
some workers confirmed a lower BMD in relation
to the B allele in adults (37, 38), others found lower
BMD values in homozygous subjects with the common
bb or the rare bbAA genotypes rather than in BB sub-
S. Ferrari, R. Rizzoli, and J-P. Bonjour 
208 Aging Clin. Exp. Res., Vol. 10, No. 3
Figure 3 - Genetic and non-genetic influences on bone mineral mass. Arrow thickness indicates the relative importance of the var-
ious factors on bone mineral mass at different time points throughout life. Dotted arrows mean that there is yet no definite proof
of an effect at this level. Double arrow-heads indicate potential interactions between genetic and non-genetic factors.
jects (39, 40), and most large scale studies in several
Western populations as well as a meta-analysis failed
to detect a significant association between BMD or
BMD changes and VDR-3’ alleles (Bsm 1) before or
after menopause (34, 35, 41, 42). It therefore appears
that VDR-3’ alleles per se are unlikely to predict low
bone mineral mass at the time of menopause, and
cannot be considered useful markers of an increased
osteoporosis risk. 
Nevertheless, an association between bone mineral
mass and VDR-3’ alleles seems to be present in chil-
dren (43, 44) and young adults (45, 46). Conse-
quently, significant BMD differences, which may be
detected in the young but are no longer present in
mature adults from the same genetic background
(44, 45), suggest that interactions between genetic
and age-related as well as environmental factors may
occur.
VDR-5’ allelic polymorphisms
Very recently, independent polymorphisms in the
VDR-5’ start codon, identified by the restriction en-
zyme Fok 1 as FF (35%), Ff (50%) and ff (15%),
were reported to be associated with lumbar spine or
femoral neck BMD differences in postmenopausal
Mexican-American women (47), and premenopausal
American white women (48), with ff subjects having
the lowest mean BMD values; however, this associa-
tion was not detected in black women. A recent report
from Japan also found decreased BMD in ff subjects
(49). In contrast, one European study in healthy pre-
menopausal women (50), and another in young adult
women as well as prepubertal girls (51) did not confirm
significant relationships between BMD and VDR-5’
start codon polymorphisms. Interestingly however,
in the latter study we observed a possible genotypic in-
teraction between VDR-3’ (Bsm 1) and VDR-5’ (Fok
1) polymorphic loci, since the lowest BMD values
were found in BBff or BBFf subjects while bbFF fe-
males had the highest BMD.
VDR-3’ ALLELIC POLYMORPHISMS AND
DIETARY CALCIUM INTERACTIONS
Bone mineral mass determination has long been
postulated to depend on gene-environment interac-
tions as well (52; Fig. 3). We first observed an inter-
action between VDR-3’ allelic polymorphisms and
dietary calcium in a vitamin D/calcium-supplementa-
tion trial addressing BMD changes in the elderly; the
mean rate of lumbar spine BMD loss was higher in BB
than bb or Bb subjects (53). A significant positive
correlation between calcium intake and BMD changes
was observed only in Bb subjects, suggesting that
the range of dietary calcium intake affecting BMD may
differ among VDR-3’ genotypes. In agreement with
this hypothesis, it was later shown that BB post-
menopausal women who had more prominent bone
loss than females with other VDR genotypes also
had a better response in terms of BMD changes to cal-
cium supplements (54). Although some discordant
findings about a possible association between post-
menopausal bone loss and VDR-3’ alleles (35, 41)
may be related to the influence of the time since
menopause on the physiology of bone loss (54, 55),
additional studies have now reported a significant in-
teraction between vitamin D and/or calcium intake
and VDR-3’ alleles on post-menopausal BMD (56-58). 
Two recent investigations also found significant
VDR-3’/dietary calcium interactions on BMD in
young adults (59) and children (44). Thus, we ob-
served that BMD gain in prepubertal girls was in-
Genetics of osteoporosis
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Table 1 - Candidate polymorphic gene markers associated with bone mineral mass.
Genes Polymorphic markers References No.
Vitamin D receptor (VDR)-3’ Bsm 1 (alternatively, Taq 1) 31
Apa 1
Vitamin D receptor (VDR)-5’ Fok 1 47
Collagen type I (COL1A1)-Sp1 binding site Msc I 63
Estrogen receptor (ER) Pvu II 65
Xba I
Transforming growth factor (TGF) β * 67
Polymorphic markers are designated as endonuclease restriction sites, except*, in which case two sequence variations (713-8delC and C788-T) were identified
as single-stranded conformation polymorphisms (SSCP). Only princeps publications of a potential association between BMD (and/or osteoporosis) and geno-
types are quoted (see text for complete list of references). This Table therefore is not a comprehensive list of all osteoporosis candidate genes under investigation.
creased at several skeletal sites in Bb and BB subjects
in response to calcium supplements (800 mg/d),
whereas it remained apparently unaffected in bb girls,
who had a trend for spontaneously higher BMD ac-
cumulation on their usual calcium diet. Moreover,
other potential gene-environmental interactions, such
as those involving physical exercise (60), as well as
gene-gene interactions (see above) might modulate
BMD-VDR-3’ genotype relationships independently of
dietary calcium.
In support of an interaction between dietary calci-
um and VDR-3’ alleles, a decreased fractional 45Ca
absorption has been found in BB as compared to bb
late postmenopausal women receiving a low, as op-
posed to a high, calcium diet (61). Decreased intesti-
nal calcium absorption has also been found in BB
black American postmenopausal women (62). Inter-
estingly though, differences in intestinal calcium ab-
sorption might also play a role in the apparent influ-
ence of dietary calcium levels on the relationship be-
tween BMD and VDR-5’ start codon polymorphisms
(48, 51).
OTHER GENE POLYMORPHISMS AND
BONE MINERAL MASS
Many genes coding for structural bone proteins, cal-
cium and phosphate regulatory hormones or modu-
lators of bone turnover, including various hormones
and cytokines, could potentially be involved in the
polygenic determination of osteoporosis. A few of
these candidate polymorphic genes, besides 3’- and 5’-
vitamin D receptor alleles, have recently been asso-
ciated with BMD and/or the prevalence of osteo-
porosis in some populations (Table 1).
A polymorphism in the first intron of the COL1A1
gene (coding for Type I collagen, the major bone
matrix protein), corresponding to a recognition site for
the Sp1 transcription factor, has been associated
with significant BMD differences at the level of the
lumbar spine in postmenopausal women (63). More-
over, COL1A1 Sp1 genotypes Ss and ss, which rep-
resented 34% and 3%, respectively, of the study co-
hort, were more frequent among women with a ver-
tebral fracture, as compared to women without it
(63). In contrast, COL1A1 Sp1 polymorphisms were
not associated with femoral neck BMD, an unex-
pected finding since Type I collagen is the major
bone constituent of the entire skeleton. Another large
population-based study in postmenopausal women,
however, found an association between COL1A1
Sp1 polymorphisms and lumbar spine as well as
femoral neck BMD (64), even though the average
BMD difference among genotypes at the femoral
neck level was about 0.2 standard deviations, and de-
tectable only above the age of 70, which remains of
questionable biological relevance. On the other hand,
odds ratios for prevalent vertebral fractures were not
significantly different among the COL1A1 Sp1 geno-
types. Interestingly, both studies suggested that the in-
fluence of COL1A1 Sp1 polymorphisms on BMD
could be more prominent in older subjects. These
observations need to be further substantiated by phys-
iological and molecular evidence of altered collagen
metabolism, such as the excretion of collagen 
N-telopeptide breakdown products (NTX) for instance,
in relation to COL1A1 Sp1 polymorphisms.
Pvu II and Xba I restriction fragment length poly-
morphisms in the first intron of the estrogen receptor
gene have also been found to be associated with
BMD in postmenopausal Japanese women, however,
without apparent changes in several markers of bone
turnover (65). These observations were not confirmed
in a similar cohort from Korea (66), and estrogen re-
ceptor allelic polymorphisms have not been thor-
oughly investigated in European Caucasian and Amer-
ican populations. 
In addition, two sequence variations were identified
in the TGF-β1 gene that might alter the structure of
the protein (see legend of Table 1) (67). These two
polymorphisms have been related to an increased
risk of osteoporosis among Danish women. However,
both TGF-β1 mutant alleles were quite uncommon,
which therefore makes it unlikely that they account for
the high prevalence of osteoporosis in Western pop-
ulations.
CONCLUSIONS
Osteoporosis, which depends on peak bone mineral
mass as well as the rate of age-related bone loss, is a
complex disorder determined by both genetic and
non-genetic factors. The recent emergence of candi-
date genes potentially associated with BMD and bone
turnover has provided an immense impetus towards
the identification of a heritable susceptibility for os-
teoporosis. Among these genes, common allelic poly-
morphisms in the 3’-end region and the 5’-start
codon region of the VDR gene have been the most
extensively investigated. Whereas these polymorphic
loci per se do not appear as definite molecular mark-
ers of osteoporosis, they have provided a new insight
into the genetic determination of peak bone mineral
mass, and re-updated the possibility of genetic influ-
ences on bone remodeling and bone loss. More im-
portantly, they have emphasized that genetic and
environmental influences on bone mineral mass can-
not be easily dissociated.
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